Skip to main content
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · IEX Real-Time Price · USD
1.905
+0.005 (0.26%)
May 1, 2024, 4:30 PM EDT - Market closed

Cue Biopharma Revenue

In the year 2023, Cue Biopharma had annual revenue of $5.49M with 340.96% growth. Revenue in the quarter ending December 31, 2023 was $1.82M with 1,105.96% year-over-year growth.

Revenue (ttm)
$5.49M
Revenue Growth
+340.96%
P/S Ratio
16.88
Revenue / Employee
$103,585
Employees
53
Market Cap
92.67M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 20203.15M-304.01K-8.79%
Dec 31, 20193.46M2.32M202.67%
Dec 31, 20181.14M--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OptiNose 70.99M
Eton Pharmaceuticals 32.64M
Elutia 24.75M
Myomo 19.24M
Curis 10.02M
Armata Pharmaceuticals 4.53M
Revenue Rankings

CUE News

More News